Press Releases

12345678910
Discovery Announces Details of Investor Day 2026
TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced that the Company will hold an Investor Day on March 2, 2026, at 11:00 am Eastern Time (“ET”), to be followed by a Q&A discussion. Details of the event are provided below. The presentation will also be webcast and available on the Company’s website at www.discoverysilver.com.
By Discovery Silver Corp. · Via GlobeNewswire · February 9, 2026
Resolve Legal Group Receives Consumer Choice Award for Family Law in Southern Alberta
CALGARY, ALBERTA / ACCESS Newswire / February 9, 2026 / Resolve Legal Group has been recognized with the 2025 Consumer Choice Award in the Family Law category for Southern Alberta. This recognition reflects the firm's unwavering dedication to delivering exceptional legal representation while providing clients with comprehensive, wraparound support services.
Via ACCESS Newswire · February 9, 2026
ReNew Announces Date and Conference Call Details for Third Quarter FY26 Earnings
ReNew Energy Global plc ("ReNew") (NASDAQ: RNW, RNWWW), India’s leading decarbonisation solutions company, today announced it will issue its third quarter (October - December) fiscal year 2026 earnings report before the US market opens on 16th February 2026 (EST).
By ReNew Energy Global plc · Via Business Wire · February 9, 2026
Fido Fuels Launches Breeder Rewards Program
Corning, California - Feb 9, 2026 - Fido Fuels by Nadelhaus, a premium dog nutrition brand founded by breeders, today announced the official launch of the Fido Fuels Breeder Rewards Program, a new initiative designed to directly support responsible breeders and the community that champions real, nutrient-dense nutrition for dogs.
Via AB Newswire · February 9, 2026
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
Maranello (Italy), February 9 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “First Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) as follows:
By Ferrari N.V. · Via GlobeNewswire · February 9, 2026
Gemdale Gold Announces Approval for Listing on the TSX Venture Exchange
VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / Gemdale Gold Inc. (TSXV:GEMG) ("Gemdale" or the "Company") is pleased to announce that the common shares in the capital of the Company (the "Common Shares") have been approved for listing on the TSX Venture Exchange (the "TSXV") and will commence trading under the ticker symbol "GEMG" at the opening of the market on February 11, 2026.
Via ACCESS Newswire · February 9, 2026
Sands & Associates Wins 2026 Consumer Choice Award for Licensed Insolvency Trustee in Vancouver, Surrey, Abbotsford, Kelowna and Victoria
VANCOUVER, BC / ACCESS Newswire / February 9, 2026 / Sands & Associates, British Columbia's largest firm of Licensed Insolvency Trustees, has been awarded the 2026 Consumer Choice Award in the Licensed Insolvency Trustee category for Vancouver, Surrey, Abbotsford, Kelowna and Victoria. Recognized for its compassionate, client-focused approach and trusted financial-recovery expertise, Sands & Associates continues to lead the province in helping individuals and families achieve a financial fresh start.
Via ACCESS Newswire · February 9, 2026
Black Book Research Releases 2026 India Digital Health & Acute Care EHR Market Report Highlighting ABDM-Driven Procurement Shift, Rapid Cloud Adoption, and a Coming HIS Replacement Wave
New findings map where providers will realize measurable ROI and where vendors can win in India's interoperability-first market cycle
Via ACCESS Newswire · February 9, 2026
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological conditions, today announced completion of enrollment in its second Phase 3 registration-directed clinical trial evaluating VDPHL01 for the treatment of male pattern hair loss. Following the previously announced completion of enrollment in Veradermics’ first Phase 2/3 trial, this milestone marks the completion of enrollment across both Phase 3 clinical trials of VDPHL01 in males, encompassing more than 1,000 participants.
By Veradermics, Incorporated · Via Business Wire · February 9, 2026
The Manitowoc Company Expands Its Direct-to-Customer Footprint; MGX Appointed Hiab Dealer for the U.S. in 13 States
The Manitowoc Company, Inc. (NYSE: MTW) (the “Company” or “Manitowoc”), announced today that its wholly-owned subsidiary, MGX Equipment Services, LLC (“MGX”), has completed a strategic dealer agreement with Hiab. The agreement expands the MGX and Manitowoc direct-to-customer footprint by adding distribution of HIAB loader cranes with aftermarket parts and service support for a diverse range of end market customers. MGX will now serve Hiab customers in the following U.S. states: Colorado, Delaware, Iowa, Maryland, Minnesota, Montana, Nebraska, New Jersey, North Dakota, South Dakota, Virginia, Wyoming, and Utah.
By The Manitowoc Company, Inc. · Via Business Wire · February 9, 2026
Haveli To Acquire Budge Studios, Leading Mobile Developer of Digital Interactive Entertainment for Children
Haveli Investments, L.P. (“Haveli” or “Haveli Investments”), a technology and gaming-focused private equity firm, today announced that it has entered into an agreement to acquire Budge Studios, a leader in digital interactive entertainment for children, from General Atlantic, a leading global investor. Creating positive and meaningful experiences to inspire kids’ imaginations, Budge Studios is entrusted by, and collaborates with, the world’s most recognized brands in children’s entertainment, including Bluey, PAW Patrol, Barbie, Disney’s Frozen, Hot Wheels and Hello Kitty. Terms of the transaction were not disclosed.
By Haveli Investments, L.P. · Via Business Wire · February 9, 2026
Context Therapeutics to Participate in Upcoming Investor Conferences
PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences.
By Context Therapeutics Inc. · Via GlobeNewswire · February 9, 2026
Abaxx Exchange Partners with ipushpull to Deliver Real-Time Market Data Directly into Microsoft Excel
TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, today announced that Abaxx Exchange has partnered with ipushpull to deliver exchange market data directly into the workflows trading firms already use through Microsoft Excel.
By Abaxx Technologies Inc. · Via GlobeNewswire · February 9, 2026
Sleep experts urge adoption of permanent standard time to protect public health as Americans prepare to ‘spring forward’
AASM and Coalition for Permanent Standard Time cite health risks, public support in call to end seasonal clock changes
Jeffs’ Brands: KeepZone AI Enters Into Anti-Submarine and Underwater Security Systems with Strategic Agreement
Exclusive agreement with a global leader in underwater domain awareness to support Mexican maritime and offshore security operations
By Jeffs' Brands Ltd · Via GlobeNewswire · February 9, 2026
Money Mentors Wins Consumer Choice Award for Credit & Debt Counselling Services in Northern Alberta
EDMONTON, AB / ACCESS Newswire / February 9, 2026 / Money Mentors, an accredited non-profit credit counselling agency serving Albertans since 1997, has been awarded the 2025 Consumer Choice Award in the Credit & Debt Counselling Services category for Northern Alberta. Recognized for its high-integrity service, client-centred education programs and its role as the exclusive provider of the Orderly Payment of Debts (OPD) program on behalf of the Government of Alberta, Money Mentors continues to set the standard for financial wellness and debt relief counselling in the region.
Via ACCESS Newswire · February 9, 2026
Zakhary Rhinoplasty & Facial Plastic Surgery Clinic Wins Consumer Choice Award for Excellence in Cosmetic Procedures
CALGARY, ALBERTA / ACCESS Newswire / February 9, 2026 / Zakhary Rhinoplasty & Facial Plastic Surgery Clinic, led by Dr. Kristina Zakhary, has been recognized with the 2025 Consumer Choice Award in the Cosmetic Procedures category for Southern Alberta. This honour highlights the clinic's longstanding reputation for excellence in facial plastic and reconstructive surgery, as well as its dedication to patient-centred care.
Via ACCESS Newswire · February 9, 2026
Performance Food Group Company Announces Intention to offer $1.06 billion of Senior Notes
Performance Food Group Company (“PFG”) (NYSE: PFGC) announced today that its indirect wholly-owned subsidiary, Performance Food Group, Inc. (the “Issuer”), intends, subject to market and other conditions, to offer $1.06 billion aggregate principal amount of Senior Notes due 2034 (the “notes”). PFG intends to use the net proceeds from the offering, together with borrowings under its revolving credit facility, to redeem all of the Issuer’s outstanding 5.500% Senior Notes due 2027, including to pay fees and expenses related thereto.
By Performance Food Group Company · Via Business Wire · February 9, 2026
Lions Park Denture Clinic Recognized With Consumer Choice Award for Denturists in Southern Alberta
CALGARY, AB / ACCESS Newswire / February 9, 2026 / Lions Park Denture Clinic has once again been recognized with the 2025 Consumer Choice Award in the Denturists category for Southern Alberta. This marks the twelfth consecutive year the clinic has received this honour, highlighting its reputation for trusted care, innovation, and dedication to helping clients regain confidence in their smiles.
Via ACCESS Newswire · February 9, 2026
One Equity Partners Agrees to Acquire Bozzetto Group
One Equity Partners (“OEP”), a middle market private equity firm, today announced that it has agreed to acquire Bozzetto Group (“Bozzetto” or “the Company”), a global specialty chemicals provider. Financial terms of the private transaction were not disclosed.
By One Equity Partners · Via Business Wire · February 9, 2026
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
- Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks 8 and 12 (p=0.0009) -
By Zenas BioPharma · Via GlobeNewswire · February 9, 2026
Burbank Chimney Services Highlights Chimney Safety Risks in Historic and Older Burbank Homes
Burbank Chimney Services is raising awareness about chimney safety risks commonly found in historic and older homes across Burbank. Many residential properties in the area were built decades ago and still rely on original chimney systems that may not meet modern safety standards.
Via AB Newswire · February 9, 2026
Pagaya Reports Fourth Quarter and Full Year Ended 2025 Results
Pagaya Technologies Ltd. (NASDAQ: PGY) (“Pagaya”, the “Company” or “we”), a global technology company delivering artificial intelligence infrastructure for the financial ecosystem, today announced financial results for the fourth quarter and full year ended 2025.
By Pagaya Technologies Ltd. · Via Business Wire · February 9, 2026
FHLBank Chicago Appoints Kahya Fox to Community Investment Advisory Council
The Federal Home Loan Bank of Chicago (FHLBank Chicago) is pleased to announce the appointment of Kahya Fox, Executive Director of Habitat for Humanity of the Greater La Crosse Region, to its Community Investment Advisory Council (Advisory Council) for a three-year term. Fox brings more than 20 years of experience in housing and community development, with a career centered on expanding the supply of safe, affordable, and energy-efficient housing for low- and moderate-income individuals and families.
By Federal Home Loan Bank of Chicago · Via Business Wire · February 9, 2026
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
MALVERN, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the appointment of Rita Johnson-Greene as Chief Financial Officer (CFO).
By Ocugen · Via GlobeNewswire · February 9, 2026
Rugiet Named Official Men’s Prescription Partner of the Detroit Pistons
Rugiet, a men’s healthcare platform, today announced its designation as the official men’s Rx partner for the Detroit Pistons. The partnership marks the franchise’s first-ever collaboration in men’s health and the first branded placement at the top of the Pistons’ backboard.
By Rugiet · Via Business Wire · February 9, 2026
The Mortgage Collaborative and Mortgage Bankers Association announce partnership agreement
SAN DIEGO, Calif., Feb. 9, 2026 (SEND2PRESS NEWSWIRE) -- The Mortgage Collaborative (TMC), the nation's largest independent cooperative network for mortgage lenders and the Mortgage Bankers Association (MBA), the national association representing the real estate finance industry, announced today that they have entered into a strategic partnership to expand advocacy, education and engagement opportunities for their members.
Via Send2Press · February 9, 2026
Global Food Premix Market Witnessing Robust Growth of USD 3.6 Billion by 2036 Amid Rising Demand for Fortified and Functional Foods
Rising Demand for Fortified and Functional Foods, Ready-to-Use Blends, and Immunity-Focused Solutions Drives Global Food Premix Market Growth
Via ACCESS Newswire · February 9, 2026
Ayrmid Appoints ACA Pharma as Exclusive Distributor for Omisirge(R) across Greater China and Southeast Asia
ACA Pharma granted exclusive rights to register and distribute Omisirge across 15 markets, covering both FDA-approved Omisirge indications
Via ACCESS Newswire · February 9, 2026
ATHA Energy Provides Post CAD $63 Million Financing Plans - Focused on Growth and Discovery at the Angilak Uranium Project
HIGHLIGHTS
Via ACCESS Newswire · February 9, 2026
Abasca Resources Announces Assay Results from the Summer 2025 Drill Program and Start of Winter Drilling at its Loki Flake Graphite Deposit
SASKATOON, SK / ACCESS Newswire / February 9, 2026 / Abasca Resources Inc. ("Abasca" or the "Company") (TSXV:ABA) is pleased to release assay results from the in-fill drilling component of its summer 2025 program at its Loki Flake Graphite Deposit (Loki Deposit) at its 100%-owned Key Lake South (KLS) Project (Figure 1, Figure 2). This component of the summer program was designed with the intent to upgrade the mineral resource classification of the initial 11.31 Mt inferred flake graphite resource at 7.65 % Cg1 which was derived principally from the results of the 2024 summer drill program. The in-fill drilling was conducted in conjunction with the geotechnical drilling completed at the beginning of the summer program (refer to the Company's release on September 8, 2025).
Via ACCESS Newswire · February 9, 2026
Eagle Plains' Partner Refined Energy Corp. Mobilizes Geophysical Team to the Dufferin West Project, Saskatchewan
CRANBROOK, BRITISH COLUMBIA / ACCESS Newswire / February 9, 2026 / Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains") is pleased to announce that partner Refined Energy Corp (CSE:RUU)(OTC:RFMCF)(FRA:CWA0) ("Refined") has mobilized a ground geophysical crew to Eagle Plains' 100% owned Dufferin West Property, Saskatchewan.
Via ACCESS Newswire · February 9, 2026
Fraser Valley Pre-Owned Wins Consumer Choice Award for Automobile Sales - Pre-Owned in Abbotsford
ABBOTSFORD, BRITISH COLUMBIA / ACCESS Newswire / February 9, 2026 / Fraser Valley Pre-Owned, a trusted dealership located in the Abbotsford AutoMall, has been awarded the 2025 Consumer Choice Award in the Automobile Sales - Pre-Owned category for the Abbotsford region. Recognized for its transparent pricing, quality selection, and customer-focused approach, Fraser Valley Pre-Owned continues to set a high standard for the pre-owned vehicle market in the Fraser Valley.
Via ACCESS Newswire · February 9, 2026
Intrepid Announces C$6.5 million Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - Intrepid Metals Corp. (TSXV: INTR) (OTCQB: IMTCF) ("Intrepid" or the "Company")...
Via Newsfile · February 9, 2026
Cheelcare Announces $1.0 Million Unsecured Note Financing
Markham, Ontario--(Newsfile Corp. - February 9, 2026) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in...
Via Newsfile · February 9, 2026
Gensource Potash Corporation Announces Next Milestone on the Tugaske Project
Saskatoon, Saskatchewan--(Newsfile Corp. - February 9, 2026) - Gensource Potash Corporation (TSXV: GSP) ("Gensource" or the "Company"), a fertilizer development company focused...
Via Newsfile · February 9, 2026
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS)
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in its Phase 1/2 PIONEER-ALS trial evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in people with amyotrophic lateral sclerosis (ALS). The participant was treated at the lead clinical trial site, the Sean M. Healey & AMG Center for ALS at Mass General Brigham, a premier treatment center for neurodegenerative diseases and pioneering research.
By VectorY Therapeutics · Via Business Wire · February 9, 2026
Select Water Solutions and LibertyStream Infrastructure Partners Announce Definitive Agreement to Build Out Commercial Lithium Carbonate Production Units in Texas; First 1,000‑Tonne Facility Slated for Commissioning by December 2026
Select Water Solutions Inc. (“Select”, NYSE: WTTR) and LibertyStream Infrastructure Partners Inc. (“LibertyStream”, TSXV: LIB | OTCQB: VLTLF | FSE: I2D) are pleased to announce that the companies have entered into a definitive agreement to deploy commercial lithium carbonate production facilities (“Carbonate Facilities”) at Select’s water treatment and recycling sites (“Select Facilities” or “Select Facility”) in the Midland Basin, Texas. The agreement outlines a three-stage development program for these Carbonate Facilities, with the initial phase (“Stage 1 Carbonate Facility”) scheduled for commissioning by the end of December 2026. The Stage 1 Carbonate Facility will have a production capacity of up to 1,000 tonnes of lithium carbonate per year for sale to U.S. customers and will be located at an existing Select Facility in Howard County, Texas.
Tayeh Capital Group Expands Team
Tayeh Capital Group (“TCG” or “the Firm”), a relationship-based and growth-focused private equity firm that takes a differentiated approach to investing and building enduring value, today announced that Yumee Song was appointed as Managing Director. In her new role, Song will invest alongside investment team leaders Dave Tayeh and Jon Ang.
By Tayeh Capital Group · Via Business Wire · February 9, 2026
Pebblebrook Hotel Trust Elects Nina P. Jones and Bill Bayless to Board of Trustees
Pebblebrook Hotel Trust (NYSE: PEB) (the “Company” or “Pebblebrook”) today announced the election of Nina P. Jones and Bill Bayless to the Board of Trustees. Ms. Jones's election is effective March 1, 2026. Mr. Bayless is expected to join the Board during the fourth quarter of 2026.
By Pebblebrook Hotel Trust · Via Business Wire · February 9, 2026
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, presented positive STARLIGHT-1 Phase I results at the 2026 ASTCT & CIBMTR Tandem Meetings (American Society for Transplantation and Cellular Therapy and Center for International Blood & Marrow Transplant Research).
By Estrella Immunopharma, Inc. · Via Business Wire · February 9, 2026
Maddox Industrial Transformer Supports Reindustrialization of American Manufacturing Startups with a Free American-Made Transformer Donation
Maddox Industrial Transformer announced a new initiative to support the resurgence of American manufacturing by donating a free, American-made transformer to a qualifying factory startup.
By Maddox Industrial Transformer · Via Business Wire · February 9, 2026
Aeva Announces Date for Fourth Quarter and Full Year 2025 Results and Conference Call
Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced it will report results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. Aeva will host a conference call and webcast to discuss the fourth quarter and full year 2025 results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.
By Aeva Technologies, Inc. · Via Business Wire · February 9, 2026
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Bruker Corporation today announced the launch of iNTApharma, a label‑free characterization platform that provides single‑particle sensitivity for the quantitative analysis of nanoscale bioparticles in native aqueous media. Introduced at SLAS 2026 in Boston, iNTApharma delivers size and concentration measurements within minutes, supporting research, therapy development and quality control workflows that require direct, native‑state assessment of bio-nanoparticle populations without labeling or chemical modifications.
By Bruker Corporation · Via Business Wire · February 9, 2026
First BanCorp. Announces Retirement of Chief Financial Officer Orlando Berges and Appointment of Successor Said Ortiz
First BanCorp. (the “Corporation”) (NYSE: FBP), the bank holding company for FirstBank Puerto Rico, announced today that Orlando Berges, Executive Vice President and Chief Financial Officer, will retire from the Corporation effective June 30, 2026, after close to 17 years of distinguished service.
By First BanCorp · Via Business Wire · February 9, 2026
JOSS Realty REIT, Inc. Announces Launch of Initial Public Offering
JOSS Realty REIT, Inc. ("JOSS" or the "Company") today announced the launch of its initial public offering of 3,000,000 shares of common stock.
By JOSS Realty REIT, Inc. · Via Business Wire · February 9, 2026
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
At SLAS2026, Chemspeed Technologies, a leader in the automation and digitalization of R&D and QC laboratories, and SciY, a leader in scientific and laboratory management software focused on lab standardization and AI-readiness, today introduce their open Self‑Driving Lab (SDL) platform. Their Self-Driving Lab platform is designed to accelerate research and development (R&D), quality control (QC) and chemical and biomolecular manufacturing workflows. The SDL enables lab managers to operationalize autonomous, AI‑orchestrated experimentation through vendor‑agnostic integration that unites modular precision automation, scientific analysis and lab management software, complete lab digitization and an AI‑ready open data backbone.
By Bruker Corporation · Via Business Wire · February 9, 2026
monday.com Announces Fourth Quarter and Fiscal Year 2025 Results
monday.com (NASDAQ: MNDY), the AI work platform that turns strategy into execution, at scale, today reported financial results for its fourth quarter and fiscal year ended December 31, 2025.
By monday.com · Via Business Wire · February 9, 2026
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 2026
Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026.
By Promega Corporation · Via Business Wire · February 9, 2026
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities
Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow.
By Eurofins Scientific · Via Business Wire · February 9, 2026